Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if ...

Jefferies, Mizuho Financial Group, and Morgan Stanley have emerged as the leading mergers and acquisitions (M&A) financial ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the hot penny stocks to invest in now. On July 16, Mizuho analyst Graig ...

Investing.com -- Sarepta Therapeutics came under pressure after two brokerages slashed their price targets and downgraded the stock, flagging mounting safety, regulatory, and credibility concerns ...

Palantir (NASDAQ:PLTR) was upgraded to Neutral from Underperform by Mizuho Securities as its sustained revenue growth has ...

Mizuho raised its rating on Brixmor Property Group (BRX) to Outperform from Neutral due to the shopping REIT's "defensive ...

Mizuho will be the first in the financial sector to introduce artificial intelligence that is being developed jointly by ...

Live market coverage co-anchored from Hong Kong and New York. Overnight on Wall Street is daytime in Asia. Markets never ...

Fluence Energy and other renewable energy companies downgraded at Mizuho, which cited the impact of President Trump's "Big ...

In a report released today, Brett Linzey from Mizuho Securities reiterated a Hold rating on 3M, with a price target of $155.00. The company’s shares opened today at $162.54. Ele ...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 7 most undervalued pot stocks to buy according to analysts.

Mizuho Bank Ltd. beat a suit Wednesday brought by a former US-based vice president accusing the bank of discrimination ...